Search

Your search keyword '"Mira Didic"' showing total 27 results

Search Constraints

Start Over You searched for: Author "Mira Didic" Remove constraint Author: "Mira Didic" Journal alzheimer's & dementia Remove constraint Journal: alzheimer's & dementia
27 results on '"Mira Didic"'

Search Results

1. Amygdalar nuclei and hippocampal subfields on MRI: Test‐retest reliability of automated segmentation in old and young healthy volunteers

2. P3‐368: PREDICTING AND MONITORING SHORT‐TERM DISEASE PROGRESSION IN A‐MCI PATIENTS WITH PRODROMAL AD USING MRI STRUCTURAL BRAIN BIOMARKERS

3. P4‐077: BLOOD INFLAMMATORY PROFILES MEASURED BY THE ADFLAG ® TEST ENABLE STRATIFICATION OF PRE‐DEMENTIA ALZHEIMER'S DISEASE

4. IC‐P‐126: VOLUMETRIC ACCURACY OF A FULLY AUTOMATIC TOOL FOR WHITE MATTER HYPERINTENSITIES (WMHS) SEGMENTATION

5. [P3–062]: ACROSS‐SESSION REPRODUCIBILITY OF AUTOMATIC WHITE MATTER HYPERINTENSITIES SEGMENTATION: A EUROPEAN MULTI‐SITE 3T STUDY

6. [P4–157]: CSF BIOMARKERS AND EFFECT OF APOLIPOPROTEIN E GENOTYPE, AGE AND SEX ON CUT‐OFF DERIVATION IN MILD COGNITIVE IMPAIRMENT

7. [IC‐P‐167]: ACROSS‐SESSION REPRODUCIBILITY OF AUTOMATIC WHITE MATTER HYPERINTENSITIES SEGMENTATION: A EUROPEAN MULTI‐SITE 3T STUDY

8. [P3–214]: ADFLAG ® , A DIAGNOSTIC BLOOD TEST FOR PRE‐DEMENTIA STAGES OF ALZHEIMER's DISEASE

9. P4‐122: Prevalence of Vascular Risk Factors in Different Stages of Prodromal Alzheimer’s Disease and Its Influence on Cognitive Decline

10. P2‐304: Deficits in Visual Recognition Memory: A Marker of Early Mesial Temporal Lobe Degeneration in Nondemented Outpatients from Memory Clinics?

11. P2‐302: CSF Beta‐Amyloid‐ and APOE Ɛ4‐Related Decline in Episodic Memory Over 12 Months Measured using the Cantab in Individuals with Amnestic MCI: Results from the European ADNI Study

12. P2‐188: Characterization of cognitive function with the cantab in individuals with amnestic mild cognitive impairment in relation to hippocampal volume, amyloid, and tau status: Preliminary baseline results from the PharmaCog/european‐ADNI study

13. IC‐04‐05: Multisite hippocampal subfields reproducibility: A european 3T study

14. IC‐P‐115: Longitudinal white matter alterations of MCI patients in WP5 PharmaCog/E‐ADNI study: Preliminary data

15. P3‐182: Hippocampal subfield changes in mild cognitive impairment patients with Alzheimer's disease pathology

16. IC‐P‐137: Longitudinal reproducibility of default‐mode network connectivity in healthy elderly participants: A multicentric resting‐state fMRI study

17. P3‐101: CROSS‐SECTIONAL BIOMARKER CHARACTERIZATION OF MILD COGNITIVE IMPAIRMENT PATIENTS IN WP5 PHARMACOG/E‐ADNI STUDY

18. IC‐P‐080: Cross‐sectional clinical, neuropsychological, neuroimaging, neurophysiological and biochemical characterization of people with mild cognitive impairment in the WP5 PharmaCog/E‐ADNI study

19. IC‐P‐044: Test‐retest reproducibility of brain morphometry, diffusion and resting‐state fMRI: A 3T consortium study

20. P3–121: Test‐retest reproducibility of brain morphometry, diffusion and resting‐state fMRI: A 3T consortium study

21. P1–151: Cross‐sectional clinical, neuropsychological, neuroimaging, neurophysiological and biochemical characterization of people with mild cognitive impairment in WP5 pharmacog/E‐ADNI study

22. O1‐07‐08: Resting brain metabolic connectivity in prodromal Alzheimer's disease: Evidence for early functional disconnection–An EADC joint project

23. O4‐05‐07: Subhippocampal dysfunction as a clinical marker of incipient Alzheimer's disease

24. P2–297: Heterogeneous atrophy of medial temporal lobe structures in patients with amnesic mild cognitive impairment

25. P2–346: Metabolic patterns in amnestic MCI patients assessed with MR spectroscopic imaging: Relationship with the type of memory impairment

26. P2–199: Grey matter loss in amnestic MCI according to the profile of memory impairment

27. IC–P–078: Brain SPECT patterns associated with different profiles of memory impairment in amnestic MCI

Catalog

Books, media, physical & digital resources